CAS 1648796-29-5

Gimsilumab

CAS: 1648796-29-5

Gimsilumab (MORAb-022) is an anti-c-Fms humanized monoclonal antibody for the study of inflammation and hypoxemia caused by COVID-19.

Pureza: 99.49% (SEC-HPLC) - 99.49% (SEC-HPLC)

Cor e Forma: Liquid

Peso molecular: 145.8 kDa

Ref: TM-T77025

Gimsilumab

CAS: 1648796-29-5

humanized anti-GM-CSF monoclonal antibody.

Ref: 3D-CLA1485